Robert K. Schultz, PhD is President for REVA Medical. Prior to joining REVA, Dr. Schultz held the positions of Vice President of Research and Development and Vice President of Technology Strategy and Licensing for Dura Pharmaceuticals, and Research Specialist for 3M Pharmaceuticals. He is a 27-year veteran of the pharma industry. Dr. Schultz obtained his PhD in Pharmaceutics and his BS degree in Pharmacy from the University of Minnesota.

Katrina Thompson brings more than 20 years of experience to her role as Vice President of Finance and Administration. Prior to joining REVA, Ms. Thompson was Vice President and Controller at Color Spot Nurseries and has held senior finance positions in the telecom, real estate, and high tech industries. Ms. Thompson is a CPA and spent her early career with Price Waterhouse. She received her BS in Business Administration from San Diego State University.



Joan Zeltinger, PhD is Vice President of Scientific Affairs. Dr. Zeltinger has 15 years of industry research and business experience. Previously she directed Advanced Tissue Sciences' bioresorbable coronary graft and tissue engineered heart valve programs. She is known for her work as Chairwoman and developer of ASTM standards for combination medical products. She has published a number of scientific manuscripts and holds 6 US issued patents. Dr. Zeltinger conducted her post-doctoral work at the School of Medicine, University of Washington. She received her PhD in Biology from the University of South Carolina, and BS in Biology from the University of North Dakota.

Jeff Anderson is the Vice President of Regulatory and Clinical Affairs. Mr. Anderson has more than 15 years of experience in the medical device industry. Prior to joining REVA, Mr. Anderson held the position of Vice President of Regulatory and Clinical Affairs at JOMED, an internationally based cardiovascular medical device company. Mr. Anderson's prior regulatory and clinical experience also includes several senior level management positions for cardiovascular, ophthalmic and surgical device manufacturers. Mr. Anderson holds a BS in Physics from California State University Fullerton. 

Don Brandom, PhD is the Vice President of Biomaterials Product Development. In his 18 years of industry experience, he has held management and product development positions in the aerospace materials, microelectronics materials and medical device industries. Dr. Brandom earned his PhD in Materials Engineering Science at Virginia Tech, and BS in Chemistry at the University of California at Davis.

Eric Schmid is Vice President of Engineering and Stent Development. Mr. Schmid has 13 years of experience in the design and development of a wide variety of medical devices and technologies. Prior to joining REVA, he was Senior Development Engineer for a privately held medical device company where he developed novel technologies for companies including Abbott Laboratories, Guidant, Medtronic and Boston Scientific. Mr. Schmid holds multiple patents in medical devices, technologies and materials. He obtained his BS in Engineering from Harvey Mudd College and completed graduate studies in Chemical Engineering at the University of California, San Diego.

Cheryl Liberatore brings more than 10 years of medical device experience to her role as Director of Corporate Development. Prior to joining REVA, Ms. Liberatore held product management and marketing communications positions at "A" Company Orthodontics and Medtronic. She received her BA degree in psychology from San Diego State University.